Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

11.1%

2 terminated/withdrawn out of 18 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

17%

3 trials in Phase 3/4

Results Transparency

40%

4 of 10 completed trials have results

Key Signals

2 recruiting4 with results

Enrollment Performance

Analytics

N/A

7(41.2%)

Phase 2

6(35.3%)

Phase 3

2(11.8%)

Phase 4

1(5.9%)

Phase 1

1(5.9%)

17Total

N/A(7)

Phase 2(6)

Phase 3(2)

Phase 4(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (18)

Showing 18 of 18 trials

NCT04930744Phase 2Completed

Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)

Role: collaborator

NCT06050356Phase 1Active Not Recruiting

First-in-Human Trial of the Novel Tuberculosis Vaccine Candidate, H107e/CAF®10b

Role: collaborator

NCT06027671Not ApplicableRecruiting

Structured Peer-delivered ART and Reentry Community Strategy

Role: collaborator

NCT06468462Phase 4Recruiting

Periodic Presumptive Treatment vs. doxyPEP for STI Control in Kenyan MSM

Role: collaborator

NCT07163143Phase 3Not Yet Recruiting

Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)

Role: collaborator

NCT04466293Not ApplicableCompleted

Choice Architecture Based TB Preventive Therapy Prescribing

Role: collaborator

NCT03340428Not ApplicableCompleted

Post-release Retention in HIV Care for Ex-inmates in South Africa

Role: collaborator

NCT05022212Phase 2Completed

Phase 2 Trial of LACTIN-V in Women at High Risk of HIV Acquisition

Role: collaborator

NCT03891901Phase 2Completed

A Clinical Trial of the Safety, Pharmacokinetics and Hematologic Effects of Imatinib on Myelopoiesis in Adults When Given With and Without Isoniazid and Rifabutin

Role: collaborator

NCT04369326Not ApplicableCompleted

Community Initiated Preventive Therapy for TB

Role: collaborator

NCT04494516Completed

Qualitative Understanding of Community TB Services Pre and Post the CHIP-TB Trial

Role: collaborator

NCT04327271Not ApplicableCompleted

Two-way Texting for VMMC Follow-up in Republic of South Africa

Role: collaborator

NCT04523090Phase 2Terminated

Catalysing the Containment of COVID-19

Role: collaborator

NCT05010291Not ApplicableCompleted

Behavioural Text Messages to Improve Retention in Care in South Africa

Role: collaborator

NCT05017324Not ApplicableUnknown

Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial

Role: collaborator

NCT02980016Phase 3Completed

Evaluation of the Effect of 3HP vs Periodic 3HP vs 6H in HIV-Positive Individuals

Role: collaborator

NCT02735590Phase 2Unknown

The Correlate of Risk Targeted Intervention Study

Role: collaborator

NCT03265977Phase 2Withdrawn

A Phase II Study of H56:IC31 in Healthy Adolescents

Role: collaborator

All 18 trials loaded